SLE is an autoimmune disease, associated with the primary site represented by vascular endothelial cell injury, and VEGF has been regarded as a key mediator of modulator of neovascularization and endothelial dysfunction. The gene discussed is VEGFA; the disease is endothelial dysfunction.